quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:00:00·56d
PRRelease
Integra LifeSciences Holdings Corporation logo

Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

IART· Integra LifeSciences Holdings Corporation
Health Care
Original source

Companies

  • IART
    Integra LifeSciences Holdings Corporation
    Health Care

Recent analyst ratings

  • Apr 15UpdateArgus-
  • Mar 31UpdateArgus-
  • Dec 2UpdateMorgan Stanley$20.00
  • Oct 7UpdateBTIG Research-
  • Jul 30UpdateBTIG Research$22.00
  • Jul 30UpdateCitigroup$23.00

Related

  • PR3d
    Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026
  • SEC8d
    Integra LifeSciences Holdings Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement
  • ANALYST8d
    Integra downgraded by Argus
  • PR16d
    Integra LifeSciences Unveils New Real-World Evidence Highlighting PriMatrix® Utilization
  • SEC17d
    SEC Form DEF 14A filed by Integra LifeSciences Holdings Corporation
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Integra LifeSciences Holdings Corporation
  • PR37d
    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer
  • INSIDER42d
    EVP & PRESIDENT, INTERNATIONAL Singh Harvinder converted options into 20,138 shares and covered exercise/tax liability with 6,652 shares, increasing direct ownership by 61% to 35,422 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022